Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Non-Current Debt (2023 - 2025)

Fractyl Health (GUTS) has disclosed Non-Current Debt for 3 consecutive years, with $30.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Debt rose 1.49% year-over-year to $30.8 million, compared with a TTM value of $30.8 million through Sep 2025, up 1.49%, and an annual FY2024 reading of $30.2 million, up 7.76% over the prior year.
  • Non-Current Debt was $30.8 million for Q3 2025 at Fractyl Health, up from $30.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $30.8 million in Q3 2025 and bottomed at $28.0 million in Q4 2023.
  • Average Non-Current Debt over 3 years is $29.5 million, with a median of $29.7 million recorded in 2025.
  • The sharpest move saw Non-Current Debt grew 7.76% in 2024, then rose 1.49% in 2025.
  • Year by year, Non-Current Debt stood at $28.0 million in 2023, then grew by 7.76% to $30.2 million in 2024, then grew by 2.02% to $30.8 million in 2025.
  • Business Quant data shows Non-Current Debt for GUTS at $30.8 million in Q3 2025, $30.0 million in Q2 2025, and $29.4 million in Q1 2025.